Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Nasal Irrigation for Chronic Rhinosinusitis
NCT03705793Phase 4Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jan 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of mometasone furoate nasal spray in chronic rhinosinusitis (CRS) (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Change in Sino-Nasal Outcome Test Scores at 8 weeks. Started Jan 2019; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT03705793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03705793.